The Anterior Uveitis Market was valued at USD 0.5 billion in 2024 and is projected to reach USD 1.2 billion by 2034, registering a CAGR of 8.5%. This growth trajectory is underpinned by several factors, including an increasing incidence of uveitis, advancements in treatment options, and a growing awareness of eye health among the population. The rising prevalence of autoimmune diseases and...